Literature DB >> 18464319

Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.

Antoine W T van Lieshout, Marjonne C W Creemers, Timothy R D J Radstake, Lammy D Elving, Piet L C M van Riel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18464319

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

Review 1.  Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis.

Authors:  Sofie Bliddal; Stina Willemoes Borresen; Ulla Feldt-Rasmussen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

2.  Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF α treatment.

Authors:  Figen Tarhan; Gonca Orük; Ozgür Niflioğlu; Serhat Ozer
Journal:  Rheumatol Int       Date:  2012-05-22       Impact factor: 2.631

3.  Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside.

Authors:  Fatemeh Rajaii; Allison N McCoy; Terry J Smith
Journal:  Expert Rev Ophthalmol       Date:  2014-06

4.  A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapy.

Authors:  Junji Kawashima; Hideaki Naoe; Yutaka Sasaki; Eiichi Araki
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.